JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
LMND
Lemonade, Inc.
There isn't enough reported data to score LMND yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
LMND Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
LMND's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like LMND.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
LMND PE Valuation
LMND has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
LMND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect LMND's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over LMND on earnings quality, reporting a profit while its opponent remains loss making.
LMND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.86 | +$0.53 |
| Q2 2026 | -$1.81 | +$1.02 |
| Q1 2026 | -$1.85 | +$1.19 |
| Q4 2025 | -$2.24 | +$0.61 |
| Q3 2025 | -$2.39 | +$0.64 |
| Q2 2025 | -$2.83 | +$0.13 |
| Q1 2025 | -$3.04 | +$0.08 |
| Q4 2024 | -$2.85 | +$0.55 |
LMND is still losing money, but far less than before: $1.86 per share over the past year, against $4.83 at its worst in late 2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over LMND on profitability, with a higher operating margin.
LMND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $336.1M | +73% |
| Q2 2026 | $294.4M | +79% |
| Q1 2026 | $258M | +71% |
| Q4 2025 | $228.1M | +53% |
| Q3 2025 | $194.5M | +42% |
| Q2 2025 | $164.1M | +35% |
| Q1 2025 | $151.2M | +27% |
| Q4 2024 | $148.8M | +29% |
LMND has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +5.8 points |
| Q2 2026 | -14% | +12 points |
| Q1 2026 | -13% | +27 points |
| Q4 2025 | -9% | +16 points |
| Q3 2025 | -19% | +30 points |
| Q2 2025 | -26% | +19 points |
| Q1 2025 | -41% | -2.7 points |
| Q4 2024 | -25% | +8.9 points |
LMND's operating margin was −13% last quarter, up 5.8 points from the same quarter a year ago, near the top of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
LMND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9M | -27% |
| Q2 2026 | -$8M | -335% |
| Q1 2026 | -$4.1M | +$45.4M |
| Q4 2025 | $17.6M | +66% |
| Q3 2025 | $2.6M | -82% |
| Q2 2025 | $3.4M | +$16.6M |
| Q1 2025 | -$49.5M | -$17.2M |
| Q4 2024 | $10.6M | +$29.1M |
LMND has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over LMND on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
LMND Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +561K shares |
| 1 year | +4.5% | +3.4M shares |
| 3 years | +11% | +7.8M shares |
| 5 years | +26% | +16M shares |
| Available history | +78% | +33.9M shares |
LMND has 78M diluted shares, up 4.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
LMND Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
LMND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.1 | Neutral |
| Stochastic | 9.9 | Oversold |
LMND's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
LMND PE vs Financial Services Sector
LMND has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over LMND on trend strength, trading above more of its moving averages.
LMND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.1 | 2.5% below |
| 20 week MA | $51.6 | 17% below |
| 50 week MA | $60.0 | 28% below |
| 100 week MA | $51.5 | 17% below |
| 200 week MA | $34.7 | 24% above |
LMND has fallen below most of its moving averages, though it's still 24% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over LMND on returns for 2026, with the stronger performance.
LMND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.4 | $125.1 | +80% |
| 2021 | $125.1 | $45.7 | -64% |
| 2022 | $45.7 | $14.4 | -68% |
| 2023 | $14.4 | $16.1 | +12% |
| 2024 | $16.1 | $39.4 | +144% |
| 2025 | $39.4 | $74.7 | +90% |
| 2026 YTD | $74.7 | $43.0 | -42% |
LMND's yearly returns have swung widely, from +144% in 2024 to −68% in 2022. It's down 42% so far in 2026.